(Q35041117)

English

Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

0 references

juvenile rheumatoid arthritis

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

Yuliya Lokhnygina

3

object named as

Yuliya Lokhnygina

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Stacey E. Tarvin

13

object named as

Stacey E Tarvin

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

Norman T Ilowite

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Kristi Prather

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Laura E Schanberg

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Melissa Elder

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Diana Milojevic

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

James W Verbsky

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Steven J Spalding

8

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Yukiko Kimura

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Lisa F Imundo

10

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Marilynn G Punaro

11

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

David D Sherry

12

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Lawrence S Zemel

14

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

James D Birmingham

15

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Beth S Gottlieb

16

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Michael L Miller

17

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Kathleen O'Neil

18

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Natasha M Ruth

19

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Carol A Wallace

20

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Nora G Singer

21

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Christy I Sandborg

22

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

publication date

1 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

66

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

2570-2579

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Long-term safety and efficacy of rilonacept in patients with systemic juvenile idiopathic arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Alternative activation in systemic juvenile idiopathic arthritis monocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Rilonacept (arcalyst), an interleukin-1 trap for the treatment of cryopyrin-associated periodic syndromes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Anakinra for systemic juvenile arthritis: the Rocky Mountain experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Comprehensive association study of genetic variants in the IL-1 gene family in systemic juvenile idiopathic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Cytokine traps: multi-component, high-affinity blockers of cytokine action

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

A Multiple Testing Procedure for Clinical Trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study.

1 reference

https://api.crossref.org/works/10.1002%2FART.38699

21 January 2018

The randomized placebo-phase design for clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FART.38699

21 January 2018

Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

25 October 2018

Preliminary definition of improvement in juvenile arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24839206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/24839206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Macrophage activation syndrome in systemic juvenile rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24839206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Candidate early predictors for progression to joint damage in systemic juvenile idiopathic arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24839206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/ART.38699

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35041117&oldid=1599233841"